Company: MIRM
Filing Date: 2025-02-26
Form Type: S-8
Source: 0001759425-25-000016
Chunk: 3

Company: Mirum Pharmaceuticals, Inc.
Filing Date: 2025-02-26
Form: S-8
Chunk 3
---
eded shall not constitute a part of this Registration Statement, except as so modified or superseded.

## Item 8. Exhibits.
The exhibits to this Registration Statement are listed below:

| Exhibit 
 Number  
 4.1     
 4.2     |     | Description                                                                                                                                                                                                                                    
 Amended and Restated Certificate of Incorporation of the Registrant (incorporated by reference to Exhibit 3.1 to the Registrant’s Current Report on Form 8-K, filed with the Commission on July 25, 2019).                                     
 Amended and Restated Bylaws of the Registrant (incorporated by reference to Exhibit 3.2 to the Registrant’s Current Report on Form 8-K, filed with the Commission on July 25, 2019).                                                           |
|:--------|:----|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 4.3     |     | Form of Common Stock Certificate of the Registrant (incorporated by reference to Exhibit 4.1 to the Registrant’s Registration Statement on Form S-1 (File No. 333-232251), filed with the Commission on July 8, 2019).                         |
| 5.1     |     | Opinion of Cooley LLP.                                                                                                                                                                                                                         |
| 23.1    |     | Consent of Independent Registered Public Accounting Firm.                                                                                                                                                                                      |
| 23.2    |     | Consent of Cooley LLP (included in Exhibit 5.1).                                                                                                                                                                                               |
| 24.1    |     | Power of Attorney (included on the signature page).                                                                                                                                                                                            |
| 99.1    |     | Mirum Pharmaceuticals, Inc. 2019 Equity Incentive Plan (incorporated by reference to Exhibit 10.3 to the Registrant’s Registration Statement on Form S-1, as amended (File No. 333-232251), filed with the Commission on July 8, 2019).        |
| 99.2    |     | Mirum Pharmaceuticals, Inc. 2019 Employee Stock Purchase Plan (incorporated by reference to Exhibit 10.6 to the Registrant’s Registration Statement on Form S-1, as amended (File No. 333-232251), filed with the Commission on July 8, 2019). |
| 107     |     | Filing Fee Table                                                                                                                                                                                                                               |

### SIGNATURES
Pursuant to the requirements of the Securities Act of 1933